Impact of immunosuppression on incidence, aetiology and outcome of ventilator-associated lower respiratory tract infections
Anne‐Sophie Moreau(Université de Lille), Saad Nseir(Hôpital Avicenne), Elisa Vedes(Hospital da Luz), Alejandro Rodríguez(Institut de Recerca Biomèdica Catalunya Sud), Ignacio Martín‐Loeches(St. James's Hospital), Anahita Rouzé(Centre Hospitalier Universitaire de Lille), Esperanza Molero Silvero(Hospital Central de la Defensa Gómez Ulla), Bruno Mégarbane(Hôpital Avicenne), Suzana Margareth Lobo(Faculdade de Medicina de São José do Rio Preto), Luís Coelho(University of Lisbon), Pedro Póvoa(University of Lisbon), Jorge I. Salluh(Universidade Federal do Rio de Janeiro), Arnaud W. Thille(Inserm), Rafael Sánchez Iniesta(Hospital General Universitario de Albacete), Laurent Argaud(Hospices Civils de Lyon), Emilio Diaz Santos(Universitat Autònoma de Barcelona), Julien Labreuche(ASTER)
Cited by 60
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k